JDD Buzz Series | Dermatologic Hazards of Nail Products
Concerns over nail salon safety typically focus on the dangers of UV lights or risks of a salon-acquired infection. A brief communication published in the October Journal of Drugs in Dermatology expands the thinking on the dermatologic hazards of nail products, both those used in the salon and at home. From unexpected nail changes to allergic reactions, the authors state that dermatologists should …
Concerns over nail salon safety typically focus on the dangers of UV lights or risks of a salon-acquired infection. A brief communication published in the October Journal of Drugs in Dermatology expands the thinking on the dermatologic hazards of nail products, both those used in the salon and at home. From unexpected nail changes to allergic reactions, the authors state that dermatologists should … Continue reading "JDD Buzz Series | Dermatologic Hazards of Nail Products"
A new type of spa is popping up in major U.S. cities. Head spas provide a mix of spa treatments for the scalp and hair as well as potentially therapeutic treatments for dermatologic conditions that affect the scalp. Some head spas offer consultation with a trichology professional, which may include trichoscopic imaging.
Dermatologists say patients are now bringing their trichoscopic images take … 
Dermatologists have several prescription treatment options for hair loss, including minoxidil, spironolactone, finasteride, and latanoprost. Yet despite the commonality of hair loss, insurance coverage of hair loss treatments is rare. An editorial published in the August Journal of Drugs in Dermatology assesses the differences in insurance coverage of these hair loss medications.
I interviewed … 
Medical school dermatology curriculum is known for its lack of representation of images of skin of color. A letter to the editor published in the July Journal of Drugs in Dermatology shows the effects on diagnostic accuracy, perception, and confidence when one medical school took action to make its pre-clerkship dermatology curriculum more diverse.
I interviewed authors Dahyeon (Esther) Kim, a … 
Use of GLP-1 agonists is becoming increasingly more common in the U.S. According to a 2024 poll, one in eight adults has at least tried this medication class. A brief communication published in the June Journal of Drugs in Dermatology shares concerns that could arise when a patient is concurrently on a GLP-1 agonist and isotretinoin.
I interviewed author Travis W. Blalock, MD, FAAD, FACMS, dire … 